Durect Corp. | Key People and Executives
James E. Brown
President, Chief Executive Officer & Director
Simon X. Benito
Independent Director
Terrence F. Blaschke
Independent Director
David R. Hoffmann
Lead Independent Director
Armand P. Neukermans
Independent Director
Jon Sheldon Saxe
Independent Director
James E. Brown
President, Chief Executive Officer & Director
Judy Joice
Senior VP-Operations & Corporate Quality Assurance
Matthew J. Hogan
CFO, Secretary & Principal Accounting Officer
Myriam Theeuwes
Senior Vice President-Clinical Development
Steve Helmer
Chief Patent Counsel & Vice President
Wei Qi Lin
Senior Vice President-Research & Development
David J. Ellis
Vice President-Clinical Development
Robert M. Janosky
Vice President- Business Development
Su Il Yum
EVP-Pharmaceutical Systems Research & Development
Michael H. Arenberg
Senior VP-Corporate & Business Development
Jian Li
Vice President-Finance & Controller
Simon X. Benito
Independent Director
Terrence F. Blaschke
Independent Director
David R. Hoffmann
Lead Independent Director
Armand P. Neukermans
Independent Director
Jon Sheldon Saxe
Independent Director
| Address |
10260 Bubb Road
Cupertino California 95014
United States
|
|
Employees
|
- |
| Website |
http://www.durect.com |
| Updated |
07/08/2019 |
| DURECT Corp. is a biopharmaceutical company, which engages in the research, development, and manufacturing of pharmaceutical products. Its product pipeline consists of multiple investigational drug candidates in clinical development. It offers DUR-928, which focuses on lipid homeostasis, inflammation, and cell survival; POSIMIR, which is an analgesic product intended to deliver bupivacaine to provide pain relief after surgery; and REMOXY ER, which provides investigational extended release pain relief. |
